Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Cornberg

Showing results (271-280 of 350) with videos related to

Pageof 35
Sort By:
Journal of Hepatology|April 18, 2016
Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimensBenjamin Maasoumy, Johannes Vermehren, Martin-Walter Welker, et al.
Plos One|December 25, 2015
Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World SettingSteffen B Wiegand, Benjamin Heidrich, Simone Susser, et al.
Clinical and Molecular Hepatology|November 21, 2024
Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosisAnja Tiede, Lena Stockhoff, Zhaoli Liu, et al.
Hepatology (Baltimore, Md.)|January 23, 2025
TIGIT expression on natural killer cell subsets is an early indicator of alleviating liver inflammation following bulevirtide treatment in chronic hepatitis DPo-Chun Chen, Katja Deterding, Sophie Anna Engelskircher, et al.
European Journal of Immunology|June 11, 2025
Origin of Hypofunctional CD103<sup>+</sup> NK Cells in Cirrhosis-Associated AscitesChristian Niehaus, Daniel Geanon, Ayesha Lietzau, et al.
JHEP Reports : Innovation in Hepatology|February 28, 2023
Sofosbuvir plus velpatasvir for 8 weeks in patients with acute hepatitis C: The HepNet acute HCV-V studyBenjamin Maasoumy, Patrick Ingiliz, Christoph D Spinner, et al.
Gut Microbes|April 21, 2025
Distinct clusters of bacterial and fungal microbiota in end-stage liver cirrhosis correlate with antibiotic treatment, intestinal barrier impairment, and systemic inflammationLaura Buttler, David A Velázquez-Ramírez, Anja Tiede, et al.
Journal of Viral Hepatitis|March 15, 2025
Frequency, Severity and Impact of Pegylated Interferon Alpha-Associated Flares in Hepatitis D InfectionSvenja Hardtke, Cihan Yurdaydin, Florin A Caruntu, et al.
Journal of Hepatology|March 13, 2024
Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis deltaMathias Jachs, Lisa Sandmann, Lukas Hartl, et al.
Journal of Viral Hepatitis|July 25, 2020
Ten-year follow-up of a randomized controlled clinical trial in chronic hepatitis deltaAnika Wranke, Svenja Hardtke, Benjamin Heidrich, et al.
Pageof 35

Showing results (271-280 of 350) with videos related to

Sort By:
Pageof 35
Journal of Hepatology|April 18, 2016
Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimensBenjamin Maasoumy, Johannes Vermehren, Martin-Walter Welker, et al.
Plos One|December 25, 2015
Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World SettingSteffen B Wiegand, Benjamin Heidrich, Simone Susser, et al.
Clinical and Molecular Hepatology|November 21, 2024
Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosisAnja Tiede, Lena Stockhoff, Zhaoli Liu, et al.
Hepatology (Baltimore, Md.)|January 23, 2025
TIGIT expression on natural killer cell subsets is an early indicator of alleviating liver inflammation following bulevirtide treatment in chronic hepatitis DPo-Chun Chen, Katja Deterding, Sophie Anna Engelskircher, et al.
European Journal of Immunology|June 11, 2025
Origin of Hypofunctional CD103<sup>+</sup> NK Cells in Cirrhosis-Associated AscitesChristian Niehaus, Daniel Geanon, Ayesha Lietzau, et al.
JHEP Reports : Innovation in Hepatology|February 28, 2023
Sofosbuvir plus velpatasvir for 8 weeks in patients with acute hepatitis C: The HepNet acute HCV-V studyBenjamin Maasoumy, Patrick Ingiliz, Christoph D Spinner, et al.
Gut Microbes|April 21, 2025
Distinct clusters of bacterial and fungal microbiota in end-stage liver cirrhosis correlate with antibiotic treatment, intestinal barrier impairment, and systemic inflammationLaura Buttler, David A Velázquez-Ramírez, Anja Tiede, et al.
Journal of Viral Hepatitis|March 15, 2025
Frequency, Severity and Impact of Pegylated Interferon Alpha-Associated Flares in Hepatitis D InfectionSvenja Hardtke, Cihan Yurdaydin, Florin A Caruntu, et al.
Journal of Hepatology|March 13, 2024
Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis deltaMathias Jachs, Lisa Sandmann, Lukas Hartl, et al.
Journal of Viral Hepatitis|July 25, 2020
Ten-year follow-up of a randomized controlled clinical trial in chronic hepatitis deltaAnika Wranke, Svenja Hardtke, Benjamin Heidrich, et al.
Pageof 35